Cost-utility analysis of a national project to reduce hypertension in Israel

Cost Effectiveness and Resource Allocation

Volumn 5, Issue , 2007, Pages

  Yosefy, Chaim ^a   Ginsberg, Gary ^b   Viskoper, Reuven ^a   Dicker, Dror ^c,e   Gavish, Dov ^d,e  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c Hasharon Medical Center   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COST CONTROL; COST UTILITY ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; HYPERTENSION; ISRAEL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERIPHERAL VASCULAR DISEASE; STAFF TRAINING; UNSTABLE ANGINA PECTORIS;

EID: 38849199735     PISSN: None     EISSN: 14787547     Source Type: Journal    
DOI: 10.1186/1478-7547-5-16     Document Type: Article

References (31)

1. Hajjar I Kotchen TA Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000 JAMA 2003, 290(2):199-206. 10.1001/jama.290.2.199 12851274
2. Staessen JA Gasowski J Wang JG Risks of untreated and treated isolated systolic hypertension in the elderly: Meta- analysis of outcome trials Lancet 2000, 355(9207):865-72. 10.1016/S0140-6736(99)07330-4 10752701
3. Fedder DO Koro CE L'Italien GJ New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: Projected impact on the size, sex, and age distribution of the treatment-eligible population Circulation 2002, 105(2):152-6. 10.1161/ hc0202.101971 11790693
4. American diabetes Association: Clinical practice recommendation Diabetes Care 2002, 25:S1-147. 10.2337/diacare.25.2007.S1 11788484
5. Pearson TA Laurora I Chu H Kafonek S The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low density lipoprotein cholesterol goals Arch Intern Med 2000, 160(4):459-67. 10.1001/archinte.160.4.459 10695686
6. EUROASPIRE A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events Eur Heart J 1997, 10:1569-82. 9347267
7. Clinical reality of coronary prevention guidelines: A comparison of EROASPIRE I and II in nine countries: EROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events Lancet 2001, 357:995-1001. 10.1016/S0140-6736(00)04235-5 11293642
8. Bernard DB Townsend RR Sylvestri MF Health and disease management: What is it and where is it going? What is the role of health and disease management in hypertension? Am J Hypertens 1998, 11:103-8S. 10.1016/ S0895-7061(98)00103-4
9. Yosefy C Dicker D Viskoper JR Tulchinsky TH Ginsberg GM Leibovitz E Gavish D The Ashkelon Hypertension Detection and Control Program (AHDC Program): A community approach to reducing cardiovascular mortality Prev Med 2003, 37(6):571-6. 10.1016/j.ypmed.2003.09.003 14636790
10. Yosefy C Ginsberg GM Dicker D Viskoper JR Tulchinsky TH Leibovitz E Gavish D IBPC Investigators Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program - initial cost utility analysis Blood Press 2003, 12(4):225-1. 10.1080/08037050310015485 14596359
11. Central Bureau of Statistics, Statistical Abstract of Israel 2006, No 57, Jerusalem http://www1.cbs.gov.il/shnatonenew.htm Accessed February 8th; 2007.
12. Health Status in Israel 2003. Israel Center for Disease Control (ICDC) Pub. No. 235, 2004.
13. Fuchs Z Viskoper JR Drexler I Nitzan H Lubin F Berlin S Almagor M Zulty L Chetrit A Mishal J Comprehensive individualised nonpharmacological treatment programme for hypertension in physician-nurse clinics: Two year follow-up J Hum Hypertens 1993, 7(6):585-591. 8114054
14. Acute Coronary Syndromes 2002, Israel Center for Disease Control (ICDC) publication Number 230 April 2003.
15. MacMahon S Peto R Cutler J Collins R Sorlie P Neaton J Abbott R Godwin J Dyer A Stamler J Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias Lancet 1990, 335:765-774. 10.1016/0140-6736(90)90878-9 1969518
16. Wang JG Staessen JA Franklin SS Fagard R Gueyffier F Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome Hypertension 2005, 45(5):907-13. 10.1161/ 01.HYP.0000165020.14745.79 15837826
17. Andersen UO Jensen G Decreasing population blood pressure is not mediated by changes in habitual physical activity Results from 15 years of follow-up Blood Press 2007, 16(1):28-35.
18. Women's Health in Israel, Israel Center for Disease Control (ICDC), 1999.
19. Bornstein NM Aronovich BD Karepov VG Gur AY Treves TA Oved M Korczyn AD The Tel Aviv Stroke Registry, 3600 Consecutive patients Stroke 1996, 27:1770-1773. 8841327
20. Dialysis patients in Israel, follow-up indices 1989-2001. Israel Center for Dialysis and Kidney Transplants Ministry of Health; 2004.
21. Chi-yuan Hsu McCulloch CE Durbinian J Go AS Iribarren C Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney Disease Arch Intern Med 2005, 165:923-8. 10.1001/ archinte.165.8.923 15851645
22. Chobanian AV Bakris GL Black HR Cushman WC Green LA Izzo JL Jones DW Materson BJ Oparil S Wright JT Roccella EJ National Heart, Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure; the JNC7 report JAMA 2003, 289(19):2560-72. 10.1001/jama.289.19.2560 12748199
23. Kanel WB Blood Pressure as a cardiovascular risk factor JAMA 1996, 275:1571-1576. 10.1001/jama.275.20.1571 8622248
24. World Health Report WHO, Geneva 2004
25. Murray CJL Lopez AD (eds) The Global Burden of Disease WHO; 1996.
26. Murray CJL Lopez AD Global Health Statistics WHO; 1996.
27. WHO Commission on MacroEconomics and Health. Macroeconomics and health: investing in health for economic development. Report of the commission on Macroeconomics and health Geneva: World Health Organization; 2001.
28. Fullard E Fowler G Gray M Promoting prevention in primary care: controlled trial of low technology, low cost approach Br Med J (Clin Res Ed) 1987, 294(6579):1080-1082. 1246229 3107700
29. Berglund G Eriksson KF Israelsson B Kjellstrom T Lindgarde F Mattiasson I Nilsson JA Stavenow L Cardiovascular risk groups and mortality in an urban swedish male population: The Malmo Preventive Project J Intern Med 1996, 239(6):489-97. 10.1046/j.1365-2796.1996.483819000.x 8656142
30. Ministry of Health, Medical Services Price List 2005 http://www.health.gov.il/english/Pages_E/ default.asp?maincat=1&catId =8&PageId=8 Accessed May 7th; 2005.
31. International Drug Price Indicator Guide http://erc.msh.org/dmpguide/ resultsdetail.cfm? Accessed May 7th; 2005.